Black Bird Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Black Bird Biotech generated cash of -$1,032,574, which is less than the previous year. Cash used in financing activities reached the amount of $577,256 last year. Net change in cash is therefore -$455,318.
Cash Flow
| 2013 | -78.48K | 0 | 80K |
|---|---|---|---|
| 2014 | -81.55K | 0 | 80K |
| 2015 | -80.17K | 0 | 70K |
| 2016 | -77.94K | 0 | 80K |
| 2017 | -75.69K | 0 | 62.75K |
| 2018 | -76.09K | 0 | 79.25K |
| 2019 | -86.32K | 0 | 82.56K |
| 2020 | -619.46K | -20K | 606.47K |
| 2021 | -992.42K | -185.70K | 1.62M |
| 2022 | -1.03M | 0 | 577.25K |
BBBT Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 499.76K | 52.97K | 85.96K | 4.73K | 1.57K | 14.51K | 12.45K | 22.62K | 24.18K | 22.66K |
Operating activities | ||||||||||
Net income | -1.65M | -1.81M | -690.15K | -121.96K | -121.11K | -110.01K | -106.26K | -112.47K | -99.51K | -89.99K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 88.91K | 109.65K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 34 | 573.34K | 23K | 45K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 34 | 573.34K | 23K | 45K | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 482 | -2.74K | 0 | -8.92K | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -13.91K | -34.78K | -30.21K | -6.58K | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 35.64K | 45.01K | 34.32K | 28.32K | 0 | 17.96K | 11.51K |
Cash generated by operating activities | -1.03M | -992.42K | -619.46K | -86.32K | -76.09K | -75.69K | -77.94K | -80.17K | -81.55K | -78.48K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 4 | -5.70K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | -185.70K | -20K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 63K | 1.71M | 530.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 503.42K | -914.1K | -25K | 0 | 0 | 62.75K | 0 | 70K | 0 | 0 |
Cash used in financing activities | 577.25K | 1.62M | 606.47K | 82.56K | 79.25K | 62.75K | 80K | 70K | 80K | 80K |
Net Change In Cash | -455.31K | 446.79K | -32.99K | -3.76K | 3.16K | -12.94K | 2.05K | -10.17K | -1.55K | 1.51K |
Cash at end of period | 44.44K | 499.76K | 52.97K | 973 | 4.73K | 1.57K | 14.51K | 12.45K | 22.62K | 24.18K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |